Renaissance Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Renaissance Pharmaceuticals's estimated annual revenue is currently $22.1M per year.
  • Renaissance Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Renaissance Pharmaceuticals has 110 Employees.
  • Renaissance Pharmaceuticals grew their employee count by 24% last year.
  • Renaissance Pharmaceuticals currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Intercept Pharm...
N/A686N/AN/A-N/A
Par Pharmaceuti...
$372.5M1853N/AN/A-N/A
Delcath Systems
N/A36N/AN/A-N/A
Renaissance Pha...
$22.1M11024%N/A-N/A
VirtualScopics
$13.5M67N/AN/A-N/A
JRS Pharma LP
$43.4M216N/AN/A-N/A
Symbio Research
$15.1M7510%N/A-N/A
Innovation Asso...
$47.4M23615%N/A4.2/5N/A
Geritrex
$5.6M28N/AN/A-N/A
Chem Rx Corp
$14.5M72N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

keywords:N/A

110

Number of Employees

$22.1M

Revenue (est)

1

Current Jobs

24%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Renaissance Pharmaceuticals News

09/03/2019 - Migraine biotech Satsuma Pharmaceuticals sets terms for $75 ...

Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...

08/16/2019 - Satsuma Pharmaceuticals, a biotech targeting migraines, files ...

Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...

09/03/2019 - Digging Up the Details on Pieris Pharmaceuticals, Inc. (PIRS)

On Friday, shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) marked ... In the meanwhile, Renaissance Technologies LLC also increased ...